VMP 42214511000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Moxonidine 400microgram tablets
BNF code 0205020M0AAABAB
Virtual Therapeutic Moiety Moxonidine
Date identifier became valid 1 Sep 2023
Previous product identifier 318708005
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Moxonidine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 400.000
Strength value numerator unit microgram
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Moxonidine 400microgram tablets (A A H Pharmaceuticals Ltd)
Moxonidine 400microgram tablets (Alliance Healthcare (Distribution) Ltd)
Moxonidine 400microgram tablets (Medihealth (Northern) Ltd)
Moxonidine 400microgram tablets (Phoenix Healthcare Distribution Ltd)
Moxonidine 400microgram tablets (Sandoz Ltd)
Moxonidine 400microgram tablets (Sigma Pharmaceuticals Plc)
Moxonidine 400microgram tablets (Teva UK Ltd)
Physiotens 400microgram tablets (Necessity Supplies Ltd)
Physiotens 400microgram tablets (Sigma Pharmaceuticals Plc)
Physiotens 400microgram tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Moxonidine 400microgram tablets 28 tablet
Moxonidine 400microgram tablets 30 tablet
Moxonidine 400microgram tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback